Cargando…
Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279169/ https://www.ncbi.nlm.nih.gov/pubmed/18347080 http://dx.doi.org/10.1085/jgp.200709881 |
_version_ | 1782152067860660224 |
---|---|
author | Xin, Wenkuan Tran, Tuan M. Richter, Wito Clark, Richard B. Rich, Thomas C. |
author_facet | Xin, Wenkuan Tran, Tuan M. Richter, Wito Clark, Richard B. Rich, Thomas C. |
author_sort | Xin, Wenkuan |
collection | PubMed |
description | An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293 cells. We monitored cAMP signals using genetically encoded cyclic nucleotide-gated (CNG) channels. This high resolution approach allowed us to make several observations. (a) Exposure of cells to 1 μM isoproterenol triggered transient increases in cAMP levels near the plasma membrane. Pretreatment of cells with 10 μM rolipram, a PDE4 inhibitor, prevented the decline in the isoproterenol-induced cAMP signals. (b) 1 μM isoproterenol triggered a sustained, twofold increase in phosphodiesterase type 4 (PDE4) activity. (c) The decline in isoproterenol-dependent cAMP levels was not significantly altered by including 20 nM PKI, a PKA inhibitor, or 3 μM 59-74E, a GRK inhibitor, in the pipette solution; however, the decline in the cAMP levels was prevented when both PKI and 59-74E were included in the pipette solution. (d) After an initial 5-min stimulation with isoproterenol and a 5-min washout, little or no recovery of the signal was observed during a second 5-min stimulation with isoproterenol. (e) The amplitude of the signal in response to the second isoproterenol stimulation was not altered when PKI was included in the pipette solution, but was significantly increased when 59-74E was included. Taken together, these data indicate that either GRK-mediated desensitization of β2ARs or PKA-mediated stimulation of PDE4 activity is sufficient to cause declines in cAMP signals. In addition, the data indicate that GRK-mediated desensitization is primarily responsible for a sustained suppression of β2AR signaling. To better understand the interplay between receptor desensitization and PDE4 activity in controlling cAMP signals, we developed a mathematical model of this system. Simulations of cAMP signals using this model are consistent with the experimental data and demonstrate the importance of receptor levels, receptor desensitization, basal adenylyl cyclase activity, and regulation of PDE activity in controlling cAMP signals, and hence, on the overall sensitivity of the system. |
format | Text |
id | pubmed-2279169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22791692008-10-01 Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling Xin, Wenkuan Tran, Tuan M. Richter, Wito Clark, Richard B. Rich, Thomas C. J Gen Physiol Articles An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293 cells. We monitored cAMP signals using genetically encoded cyclic nucleotide-gated (CNG) channels. This high resolution approach allowed us to make several observations. (a) Exposure of cells to 1 μM isoproterenol triggered transient increases in cAMP levels near the plasma membrane. Pretreatment of cells with 10 μM rolipram, a PDE4 inhibitor, prevented the decline in the isoproterenol-induced cAMP signals. (b) 1 μM isoproterenol triggered a sustained, twofold increase in phosphodiesterase type 4 (PDE4) activity. (c) The decline in isoproterenol-dependent cAMP levels was not significantly altered by including 20 nM PKI, a PKA inhibitor, or 3 μM 59-74E, a GRK inhibitor, in the pipette solution; however, the decline in the cAMP levels was prevented when both PKI and 59-74E were included in the pipette solution. (d) After an initial 5-min stimulation with isoproterenol and a 5-min washout, little or no recovery of the signal was observed during a second 5-min stimulation with isoproterenol. (e) The amplitude of the signal in response to the second isoproterenol stimulation was not altered when PKI was included in the pipette solution, but was significantly increased when 59-74E was included. Taken together, these data indicate that either GRK-mediated desensitization of β2ARs or PKA-mediated stimulation of PDE4 activity is sufficient to cause declines in cAMP signals. In addition, the data indicate that GRK-mediated desensitization is primarily responsible for a sustained suppression of β2AR signaling. To better understand the interplay between receptor desensitization and PDE4 activity in controlling cAMP signals, we developed a mathematical model of this system. Simulations of cAMP signals using this model are consistent with the experimental data and demonstrate the importance of receptor levels, receptor desensitization, basal adenylyl cyclase activity, and regulation of PDE activity in controlling cAMP signals, and hence, on the overall sensitivity of the system. The Rockefeller University Press 2008-04 /pmc/articles/PMC2279169/ /pubmed/18347080 http://dx.doi.org/10.1085/jgp.200709881 Text en Copyright © 2008, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Xin, Wenkuan Tran, Tuan M. Richter, Wito Clark, Richard B. Rich, Thomas C. Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title | Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title_full | Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title_fullStr | Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title_full_unstemmed | Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title_short | Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling |
title_sort | roles of grk and pde4 activities in the regulation of β(2) adrenergic signaling |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279169/ https://www.ncbi.nlm.nih.gov/pubmed/18347080 http://dx.doi.org/10.1085/jgp.200709881 |
work_keys_str_mv | AT xinwenkuan rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling AT trantuanm rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling AT richterwito rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling AT clarkrichardb rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling AT richthomasc rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling |